## Abstract ## Background: Various assays are used to enumerate peripheral blood absolute CD4+ T‐lymphocytes. Flow cytometry is considered the gold standard for this purpose. However, the high cost of available flow cytometers and monoclonal antibody reagents make it difficult to implement such me
High frequency and proliferation of CD4+FOXP3+ Treg in HIV-1-infected patients with low CD4 counts
✍ Scribed by Xiuqiong Bi; Yasuhiro Suzuki; Hiroyuki Gatanaga; Shinichi Oka
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 224 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The frequency of Treg is reported to be higher in patients with chronic HIV type 1 (HIV‐1) infection and CD45RA^+^ Treg exist in normal adults. In this study, we found a lower absolute number (15 cells/μL) but a higher proportion (16.2%) of FOXP3^+^ cells (Treg) in the CD4^+^ population in treatment‐naïve HIV‐1 patients with low CD4 (<200 cells/μL) counts than in those with high CD4 counts (34 cells/μL and 9.3%) or healthy adults (48 cells/μL and 7.5%). In HIV‐1 patients, CD45RA^+^CCR7^+^, CD45RA^−^CCR7^+^, and CD45RA^−^CCR7^−^ subsets were identified in the Treg population, and the proportion of CD45RA^−^CCR7^−^ Treg was higher (57.9%) in patients with low CD4 than high CD4 counts (38.3%). Treg were in a high proliferation state especially in patients with low CD4 counts. HIV viral load correlated positively with the Treg proliferation rate and the proportion of CD45RA^−^CCR7^−^ Treg. Furthermore, the proliferation of Treg correlated positively with the CD45RA^−^CCR7^−^ Treg proportion but negatively with Treg numbers. Successful antiretroviral therapy resulted in a limited increase in Treg numbers, but their frequency was reduced in 1–2 months due to a rapid rebound of FOXP3^−^ CD4^+^cells. Our results suggest that HIV‐activating Treg may be a reason for the high frequencies of Treg and CD45RA^−^CCR7^−^ Treg in the peripheral blood of late‐stage HIV‐1‐infected patients.
📜 SIMILAR VOLUMES
## Abstract We analyzed changes in plasma human immunodeficiency virus (HIV)‐1 viral load, CD4+ T‐cell count, and markers of immune activation markers at start of treatment of tuberculosis and 12 months after among 44 HIV‐1‐infected patients with newly diagnosed, sputum‐smear positive for __Mycobac